Search for "dbv"

News Wire ~ 3rd Party Press Release - 2020/02/22 0

Next step in the approval process for the therapy scheduled for May 15, 2020.

Dave Bloom - 2019/09/15 0

What it is, what it treats, who it is for, how it is used, et al.

Dave Bloom - 2019/08/08 0

DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut for the Treatment of Peanut Allergy (+4 Articles)

News Wire ~ 3rd Party Press Release - 2019/07/11 0

FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.

Dave Bloom - 2019/07/11 0

The AAFA addresses concerns regarding the Final Evidence Report released by the ICER.

News Wire ~ 3rd Party Press Release - 2019/07/11 0

The report evaluates Viaskin® Peanut and AR101, as well as non-commercialized oral immunotherapy (OIT).

News Wire ~ 3rd Party Press Release - 2019/06/14 0

Affirms Burden of Food Allergies on Families, Patients, and Caregivers.

News Wire ~ 3rd Party Press Release - 2019/06/13 0

Organizations representing patients and allergists urge ICER to adopt a more patient-driven approach to assessing immunotherapies for peanut allergy.

News Wire ~ 3rd Party Press Release - 2018/09/12 0

Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.

Dave Bloom - 2018/02/28 0

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.

dbv - search results